Need help finding what you are looking for?
Contact Us
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1802110
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1802110
Global Radioimmunoassay Market Size study & Forecast, by Product Type (Immunoradiometric Assay, Radiobinding Assay, Radioreceptor Assay), by Application (Oncology, Infectious Disease, Endocrinology, Immunology), and Regional Forecasts 2025-2035
PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The Global Radioimmunoassay Market is valued at approximately USD 0.61 billion in 2024 and is anticipated to expand with a CAGR of more than 5.54% over the forecast period 2025-2035. Radioimmunoassay (RIA) represents one of the most reliable, sensitive, and specific laboratory techniques used for the quantification of antigens, hormones, and other biological markers. It leverages radioactive isotopes to measure molecular concentrations at extremely low levels, thus ensuring diagnostic accuracy across a range of clinical applications. The market growth is largely driven by the increasing prevalence of chronic diseases, a growing demand for precise diagnostic techniques, and the rising importance of hormone level monitoring in both clinical and research domains. Furthermore, technological refinements in detection methods and improved sensitivity of assay kits are propelling adoption in hospitals, diagnostic centers, and research institutes.
The rising incidence of cancer and endocrine disorders has significantly elevated the utilization of radioimmunoassays, owing to their ability to provide accurate biomarker quantification even in minute concentrations. These assays are indispensable for disease monitoring, drug efficacy evaluation, and therapeutic decision-making. According to the World Health Organization, the global cancer burden reached nearly 20 million new cases in 2022, while endocrine-related conditions such as thyroid dysfunctions and diabetes continue to surge globally. As the demand for precise diagnostic and monitoring tools intensifies, RIA techniques are being increasingly integrated into both clinical workflows and translational research. However, the stringent regulatory landscape surrounding radioactive substances and the increasing shift toward non-radioactive immunoassays are potential headwinds that could restrain market expansion across the forecast horizon.
The detailed segments and sub-segments included in the report are:
By Product Type:
- Immunoradiometric Assay
- Radiobinding Assay
- Radioreceptor Assay
By Application:
- Oncology
- Infectious Disease
- Endocrinology
- Immunology
By End User:
- Hospitals
- Diagnostic Centers
- Research Institutes
By Detection Method:
- Solid-Phase Radioimmunoassay
- Liquid-Phase Radioimmunoassay
By Sample Type:
- Serum
- Plasma
- Urine
- Saliva
- Oncology is expected to dominate the market, capturing the largest share during the forecast period. This dominance is attributable to the mounting prevalence of cancer worldwide, coupled with the pressing need for early and accurate detection methods. Radioimmunoassays have been particularly influential in oncology, offering precise detection of tumor markers and aiding oncologists in both diagnosis and treatment planning. The segment benefits from robust demand in hospitals and diagnostic centers where cancer screening programs are gaining traction, thereby reinforcing its stronghold in the market.
- From a revenue standpoint, hospitals are projected to remain the leading end-user segment throughout the forecast period. Hospitals continue to be the primary setting for radioimmunoassay utilization, owing to their comprehensive infrastructure, high patient inflow, and integration of advanced diagnostic laboratories. Their dominance is reinforced by their ability to handle large-scale testing, offer multidisciplinary care, and incorporate RIA into complex treatment regimens. While research institutes and diagnostic centers are expected to witness accelerated growth, hospitals will continue to generate the lion's share of market revenue due to their pivotal role in advanced healthcare delivery.
- The key regions considered for the Global Radioimmunoassay Market study include North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America held the lion's share in 2025, driven by the region's advanced healthcare infrastructure, high diagnostic expenditure, and rapid adoption of technologically advanced assays. The United States, in particular, has been at the forefront of adopting RIA for oncology and endocrinology diagnostics, supported by substantial R&D investment and favorable reimbursement frameworks. Meanwhile, Asia Pacific is projected to exhibit the fastest growth during the forecast period, fueled by expanding healthcare access, rapid urbanization, and escalating disease prevalence in highly populous nations such as China and India. Increasing government initiatives to enhance diagnostic capacity and the growing establishment of advanced laboratories across the region are further amplifying market growth.
Major market players included in this report are:
- PerkinElmer Inc.
- Thermo Fisher Scientific Inc.
- Siemens Healthineers AG
- Beckman Coulter Inc.
- DiaSorin S.p.A.
- Merck KGaA
- Abcam plc
- Randox Laboratories Ltd.
- Bio-Rad Laboratories Inc.
- MP Biomedicals LLC
- Cisbio Bioassays
- DRG International Inc.
- IBL International GmbH
- Euro Diagnostica AB
- Berthold Technologies GmbH & Co. KG
Global Radioimmunoassay Market Report Scope:
- Historical Data - 2023, 2024
- Base Year for Estimation - 2024
- Forecast period - 2025-2035
- Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:
Key Takeaways:
- Market Estimates & Forecast for 10 years from 2025 to 2035.
- Annualized revenues and regional-level analysis for each market segment.
- Detailed analysis of the geographical landscape with country-level analysis of major regions.
- Competitive landscape with information on major players in the market.
- Analysis of key business strategies and recommendations on future market approach.
- Analysis of the competitive structure of the market.
- Demand side and supply side analysis of the market.
Table of Contents
Chapter 1. Global Radioimmunoassay Market Report Scope & Methodology
- 1.1. Research Objective
- 1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
- 1.3. Research Attributes
- 1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
- 1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study
Chapter 2. Executive Summary
- 2.1. CEO/CXO Standpoint
- 2.2. Strategic Insights
- 2.3. ESG Analysis
- 2.4. key Findings
Chapter 3. Global Radioimmunoassay Market Forces Analysis
- 3.1. Market Forces Shaping The Global Radioimmunoassay Market (2024-2035)
- 3.2. Drivers
- 3.2.1. Increasing prevalence of chronic diseases
- 3.2.2. Growing demand for precise diagnostic techniques
- 3.3. Restraints
- 3.3.1. The stringent regulatory landscape surrounding radioactive substances
- 3.4. Opportunities
- 3.4.1. Technological refinements in detection methods and improved sensitivity of assay kits
Chapter 4. Global Spacer Fluid Industry Analysis
- 4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Porter's 5 Force Forecast Model (2024-2035)
- 4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
- 4.4. Top Investment Opportunities
- 4.5. Top Winning Strategies (2025)
- 4.6. Market Share Analysis (2024-2025)
- 4.7. Global Pricing Analysis And Trends 2025
- 4.8. Analyst Recommendation & Conclusion
Chapter 5. Global Radioimmunoassay Market Size & Forecasts by Prosuct Type 2025-2035
- 5.1. Market Overview
- 5.2. Global Radioimmunoassay Market Performance - Potential Analysis (2025)
- 5.3. Immunoradiometric Assay
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
- 5.4. Radiobinding Assay
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
- 5.5. Radioreceptor Assay
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035
Chapter 6. Global Radioimmunoassay Market Size & Forecasts by Application 2025-2035
- 6.1. Market Overview
- 6.2. Global Radioimmunoassay Market Performance - Potential Analysis (2025)
- 6.3. Oncology
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
- 6.4. Infectious DIsease
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035
- 6.5. Endocrinology
- 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.5.2. Market size analysis, by region, 2025-2035
- 6.6. Immunology
- 6.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.6.2. Market size analysis, by region, 2025-2035
Chapter 7. Global Radioimmunoassay Market Size & Forecasts by End User 2025-2035
- 7.1. Market Overview
- 7.2. Global Radioimmunoassay Market Performance - Potential Analysis (2025)
- 7.3. Hospitals
- 7.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.3.2. Market size analysis, by region, 2025-2035
- 7.4. Diagnostic Centers
- 7.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.4.2. Market size analysis, by region, 2025-2035
- 7.5. Research Institutes
- 7.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.5.2. Market size analysis, by region, 2025-2035
Chapter 8. Global Radioimmunoassay Market Size & Forecasts by Detection Method 2025-2035
- 8.1. Market Overview
- 8.2. Global Radioimmunoassay Market Performance - Potential Analysis (2025)
- 8.3. Solid-Phase Radioimmunoassay
- 8.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 8.3.2. Market size analysis, by region, 2025-2035
- 8.4. Liquid-Phase Radioimmunoassay
- 8.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 8.4.2. Market size analysis, by region, 2025-2035
Chapter 9. Global Radioimmunoassay Market Size & Forecasts by Region 2025-2035
- 9.1. Growth Radioimmunoassay Market, Regional Market Snapshot
- 9.2. Top Leading & Emerging Countries
- 9.3. North America Radioimmunoassay Market
- 9.3.1. U.S. Radioimmunoassay Market
- 9.3.1.1. Product Type breakdown size & forecasts, 2025-2035
- 9.3.1.2. Application breakdown size & forecasts, 2025-2035
- 9.3.1.3. End Use breakdown size & forecasts, 2025-2035
- 9.3.1.4. Detection Method breakdown size & forecasts, 2025-2035
- 9.3.2. Canada Radioimmunoassay Market
- 9.3.2.1. Product Type breakdown size & forecasts, 2025-2035
- 9.3.2.2. Application breakdown size & forecasts, 2025-2035
- 9.3.2.3. End Use breakdown size & forecasts, 2025-2035
- 9.3.2.4. Detection Method breakdown size & forecasts, 2025-2035
- 9.3.1. U.S. Radioimmunoassay Market
- 9.4. Europe Radioimmunoassay Market
- 9.4.1. UK Radioimmunoassay Market
- 9.4.1.1. Product Type breakdown size & forecasts, 2025-2035
- 9.4.1.2. Application breakdown size & forecasts, 2025-2035
- 9.4.1.3. End Use breakdown size & forecasts, 2025-2035
- 9.4.1.4. Detection Method breakdown size & forecasts, 2025-2035
- 9.4.2. Germany Radioimmunoassay Market
- 9.4.2.1. Product Type breakdown size & forecasts, 2025-2035
- 9.4.2.2. Application breakdown size & forecasts, 2025-2035
- 9.4.2.3. End Use breakdown size & forecasts, 2025-2035
- 9.4.2.4. Detection Method breakdown size & forecasts, 2025-2035
- 9.4.3. France Radioimmunoassay Market
- 9.4.3.1. Product Type breakdown size & forecasts, 2025-2035
- 9.4.3.2. Application breakdown size & forecasts, 2025-2035
- 9.4.3.3. End Use breakdown size & forecasts, 2025-2035
- 9.4.3.4. Detection Method breakdown size & forecasts, 2025-2035
- 9.4.4. Spain Radioimmunoassay Market
- 9.4.4.1. Product Type breakdown size & forecasts, 2025-2035
- 9.4.4.2. Application breakdown size & forecasts, 2025-2035
- 9.4.4.3. End Use breakdown size & forecasts, 2025-2035
- 9.4.4.4. Detection Method breakdown size & forecasts, 2025-2035
- 9.4.5. Italy Radioimmunoassay Market
- 9.4.5.1. Product Type breakdown size & forecasts, 2025-2035
- 9.4.5.2. Application breakdown size & forecasts, 2025-2035
- 9.4.5.3. End Use breakdown size & forecasts, 2025-2035
- 9.4.5.4. Detection Method breakdown size & forecasts, 2025-2035
- 9.4.6. Rest of Europe Radioimmunoassay Market
- 9.4.6.1. Product Type breakdown size & forecasts, 2025-2035
- 9.4.6.2. Application breakdown size & forecasts, 2025-2035
- 9.4.6.3. End Use breakdown size & forecasts, 2025-2035
- 9.4.6.4. Detection Method breakdown size & forecasts, 2025-2035
- 9.4.1. UK Radioimmunoassay Market
- 9.5. Asia Pacific Radioimmunoassay Market
- 9.5.1. China Radioimmunoassay Market
- 9.5.1.1. Product Type breakdown size & forecasts, 2025-2035
- 9.5.1.2. Application breakdown size & forecasts, 2025-2035
- 9.5.1.3. End Use breakdown size & forecasts, 2025-2035
- 9.5.1.4. Detection Method breakdown size & forecasts, 2025-2035
- 9.5.2. India Radioimmunoassay Market
- 9.5.2.1. Product Type breakdown size & forecasts, 2025-2035
- 9.5.2.2. Application breakdown size & forecasts, 2025-2035
- 9.5.2.3. End Use breakdown size & forecasts, 2025-2035
- 9.5.2.4. Detection Method breakdown size & forecasts, 2025-2035
- 9.5.3. Japan Radioimmunoassay Market
- 9.5.3.1. Product Type breakdown size & forecasts, 2025-2035
- 9.5.3.2. Application breakdown size & forecasts, 2025-2035
- 9.5.3.3. End Use breakdown size & forecasts, 2025-2035
- 9.5.3.4. Detection Method breakdown size & forecasts, 2025-2035
- 9.5.4. Australia Radioimmunoassay Market
- 9.5.4.1. Product Type breakdown size & forecasts, 2025-2035
- 9.5.4.2. Application breakdown size & forecasts, 2025-2035
- 9.5.4.3. End Use breakdown size & forecasts, 2025-2035
- 9.5.4.4. Detection Method breakdown size & forecasts, 2025-2035
- 9.5.5. South Korea Radioimmunoassay Market
- 9.5.5.1. Product Type breakdown size & forecasts, 2025-2035
- 9.5.5.2. Application breakdown size & forecasts, 2025-2035
- 9.5.5.3. End Use breakdown size & forecasts, 2025-2035
- 9.5.5.4. Detection Method breakdown size & forecasts, 2025-2035
- 9.5.6. Rest of APAC Radioimmunoassay Market
- 9.5.6.1. Product Type breakdown size & forecasts, 2025-2035
- 9.5.6.2. Application breakdown size & forecasts, 2025-2035
- 9.5.6.3. End Use breakdown size & forecasts, 2025-2035
- 9.5.6.4. Detection Method breakdown size & forecasts, 2025-2035
- 9.5.1. China Radioimmunoassay Market
- 9.6. Latin America Radioimmunoassay Market
- 9.6.1. Brazil Radioimmunoassay Market
- 9.6.1.1. Product Type breakdown size & forecasts, 2025-2035
- 9.6.1.2. Application breakdown size & forecasts, 2025-2035
- 9.6.1.3. End Use breakdown size & forecasts, 2025-2035
- 9.6.1.4. Detection Method breakdown size & forecasts, 2025-2035
- 9.6.2. Mexico Radioimmunoassay Market
- 9.6.2.1. Product Type breakdown size & forecasts, 2025-2035
- 9.6.2.2. Application breakdown size & forecasts, 2025-2035
- 9.6.2.3. End Use breakdown size & forecasts, 2025-2035
- 9.6.2.4. Detection Method breakdown size & forecasts, 2025-2035
- 9.6.1. Brazil Radioimmunoassay Market
- 9.7. Middle East and Africa Radioimmunoassay Market
- 9.7.1. UAE Radioimmunoassay Market
- 9.7.1.1. Product Type breakdown size & forecasts, 2025-2035
- 9.7.1.2. Application breakdown size & forecasts, 2025-2035
- 9.7.1.3. End Use breakdown size & forecasts, 2025-2035
- 9.7.1.4. Detection Method breakdown size & forecasts, 2025-2035
- 9.7.2. Saudi Arabia (KSA) Radioimmunoassay Market
- 9.7.2.1. Product Type breakdown size & forecasts, 2025-2035
- 9.7.2.2. Application breakdown size & forecasts, 2025-2035
- 9.7.2.3. End Use breakdown size & forecasts, 2025-2035
- 9.7.2.4. Detection Method breakdown size & forecasts, 2025-2035
- 9.7.3. South Africa Radioimmunoassay Market
- 9.7.3.1. Product Type breakdown size & forecasts, 2025-2035
- 9.7.3.2. Application breakdown size & forecasts, 2025-2035
- 9.7.3.3. End Use breakdown size & forecasts, 2025-2035
- 9.7.3.4. Detection Method breakdown size & forecasts, 2025-2035
- 9.7.1. UAE Radioimmunoassay Market
Chapter 10. Competitive Intelligence
- 10.1. Top Market Strategies
- 10.2. PerkinElmer Inc.
- 10.2.1. Company Overview
- 10.2.2. Key Executives
- 10.2.3. Company Snapshot
- 10.2.4. Financial Performance (Subject to Data Availability)
- 10.2.5. Product/Services Port
- 10.2.6. Recent Development
- 10.2.7. Market Strategies
- 10.2.8. SWOT Analysis
- 10.3. Thermo Fisher Scientific Inc.
- 10.4. Siemens Healthineers AG
- 10.5. Beckman Coulter Inc.
- 10.6. DiaSorin S.p.A.
- 10.7. Merck KGaA
- 10.8. Abcam plc
- 10.9. Randox Laboratories Ltd.
- 10.10. Bio-Rad Laboratories Inc.
- 10.11. MP Biomedicals LLC
- 10.12. Cisbio Bioassays
- 10.13. DRG International Inc.
- 10.14. IBL International GmbH
- 10.15. Euro Diagnostica AB
- 10.16. Berthold Technologies GmbH & Co. KG
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.